Lamivudine: Difference between revisions
From IDWiki
(Created page with " == Pediatric Dosing == === Neonatal HIV prophylaxis === * ≥32 weeks gestation at birth: 2 mg/kg PO q12h until age 4 weeks, then 4 mg/kg (max 150 mg) PO q12h Category:HIV...") |
No edit summary |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
| + | * [[HIV]] treatment: 150 mg p.o. twice daily or 300 mg p.o. once daily |
||
| ⚫ | |||
| + | * [[Hepatitis B]]: 100 mg p.o. once daily |
||
| ⚫ | |||
| + | |||
| + | === Renal Dosing === |
||
| + | |||
| + | * GFR >=50: usual dosing |
||
| + | * GFR 30-49: 150 mg p.o. once daily. |
||
| + | * GFR 15-29: 150 mg p.o. on day 1 followed by 100 mg p.o. once daily |
||
| + | * GFR 5-14: 150 mg p.o. on daily 1 followed by 50 mg p.o. once daily |
||
| + | * GFR <5: 50 mg p.o. on day 1 followed by 25 mg p.o. once daily |
||
| + | * Hemodialysis: 50 mg p.o. once followd by 25 mg p.o. once daily post dialysis |
||
| + | * Peritoneal dialysis: 50 mg p.o. once followed by 25 mg p.o. once daily |
||
| + | |||
| + | === Pediatric Dosing === |
||
| + | |||
| ⚫ | |||
* ≥32 weeks gestation at birth: 2 mg/kg PO q12h until age 4 weeks, then 4 mg/kg (max 150 mg) PO q12h |
* ≥32 weeks gestation at birth: 2 mg/kg PO q12h until age 4 weeks, then 4 mg/kg (max 150 mg) PO q12h |
||
Latest revision as of 13:15, 16 January 2023
Dosing
- HIV treatment: 150 mg p.o. twice daily or 300 mg p.o. once daily
- Hepatitis B: 100 mg p.o. once daily
Renal Dosing
- GFR >=50: usual dosing
- GFR 30-49: 150 mg p.o. once daily.
- GFR 15-29: 150 mg p.o. on day 1 followed by 100 mg p.o. once daily
- GFR 5-14: 150 mg p.o. on daily 1 followed by 50 mg p.o. once daily
- GFR <5: 50 mg p.o. on day 1 followed by 25 mg p.o. once daily
- Hemodialysis: 50 mg p.o. once followd by 25 mg p.o. once daily post dialysis
- Peritoneal dialysis: 50 mg p.o. once followed by 25 mg p.o. once daily
Pediatric Dosing
Neonatal HIV prophylaxis
- ≥32 weeks gestation at birth: 2 mg/kg PO q12h until age 4 weeks, then 4 mg/kg (max 150 mg) PO q12h
